SCHEMBL29772341

SCHEMBL29772341

CCCO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](COS(=O)(=O)O)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 2/20 0.52
▸ LGALS3 P17931 2/20 0.52
▸ LGALS4 P56470 2/20 0.52
▸ HPSE Q9Y251 3/20 0.47
▸ CA2 P00918 2/20 0.45
▸ CD209 Q9NNX6 1/20 0.44
▸ FGF1 P05230 1/20 0.43
▸ IGF2R P11717 2/20 0.43
▸ ENGASE Q8NFI3 1/20 0.43
▸ PTN P21246 1/20 0.42
▸ MDK P21741 1/20 0.42
▸ BDNF P23560 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ AMY1A P0DUB6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4761249 0.86 CA2 (0.53) LGALS8LGALS3LGALS4HPSECA2
SCHEMBL9276971 0.86 CA2 (0.53) LGALS8LGALS3LGALS4HPSECA2
SCHEMBL29068320 0.86 CA2 (0.53) LGALS8LGALS3LGALS4HPSECA2
SCHEMBL30089439 0.86 CA2 (0.53) LGALS8LGALS3LGALS4HPSECA2
SCHEMBL6815726 0.85 LGALS3 (0.67) LGALS8LGALS3LGALS4CD209IGF2R
SCHEMBL17263250 0.85 LGALS3 (0.67) LGALS8LGALS3LGALS4CD209IGF2R
SCHEMBL18386243 0.85 LGALS3 (0.67) LGALS8LGALS3LGALS4CD209IGF2R
SCHEMBL10292030 0.85 LGALS3 (0.67) LGALS8LGALS3LGALS4CD209IGF2R
SCHEMBL15883873 0.85 LGALS3 (0.67) LGALS8LGALS3LGALS4CD209IGF2R
SCHEMBL17547755 0.85 LGALS3 (0.67) LGALS8LGALS3LGALS4CD209IGF2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116744967-A Adjuvants comprising glycosyl archaeol and immunostimulant 加拿大国家研究委员会 2023-09-12 — — CN disclosed
Send feedback